E.P. Taylor Professor of Pain Studies, McGill University

Dr. Mogil has made seminal contributions to the field of pain research, founding the significant new subfield of pain genetics. His demonstrations of the effect of strain, sex, social factors, and laboratory environmental variables on pain behaviour in animals have improved the design and interpretation of biomedical experiments worldwide and led to changes in research policy. His discovery of empathy in rodents, facial expressions of pain in laboratory animals, and successful mouse-to-human translational findings have implications not only for analgesic drug development, but also for ...

Professor of Cognitive Neuroscience and Imaging, Western University

Adrian M. Owen OBE, FRSC, PhD, is Professor of Cognitive Neuroscience and Imaging at the University of Western Ontario, Canada and co-directs the CIFAR Brain, Mind, and Consciousness program. His research combines structural and functional neuroimaging with neuropsychological studies of brain-injured patients. Owen has published over 400 scientific articles and chapters and a best-selling popular science book ‘Into the Gray Zone’. In 2019, he was awarded an OBE by Queen Elizabeth II for services to scientific research.

Canada Research Chair, Epidemiology & Global Health, McGill University

Prof Madhukar Pai, MD, PhD, FCAHS is a Canada Research Chair in Epidemiology & Global Health at McGill University, Montreal. He is the Director of McGill Global Health Programs, and Associate Director of the McGill International TB Centre. Madhu Pai did his medical training and community medicine residency in Vellore, India. He completed his PhD in epidemiology at UC Berkeley, and a postdoctoral fellowship at the UCSF. Madhu serves on the STAG-TB committee of WHO, Geneva; Scientific Advisory Committee of FIND, Geneva; and Access Advisory Committee of TB Alliance, New York. He serves as ...

Quebec Chief Scientist, Quebec Ministry of Economy, Innovation & Energy

Remi Quirion is a McGill University Professor and Scientific Director at the Douglas Hospital Research Centre. His research interests include key phenotypes of the Alzheimer’s brain and the molecular and pharmacological features of the neuropeptide receptors NPY and CGRP. Dr. Quirion has published 5 books and more than 500 scientific papers and articles, and is the inaugural Scientific Director of the CIHR Institute of Neurosciences, Mental Health and Addiction. He has received numerous awards including Fellow of the Royal Society of Canada, Chevalier of the Ordre national du Québec, the ...

Bruce McManus was Director of the Cardiovascular Registry and the cardiovascular pathology service at the University of Nebraska Medical Centre. In 1993 he became the Head of the Department of Pathology and Laboratory Medicine at UBC and has remained a Professor in that department. He is an active researcher and co-Director of the James Hogg iCAPTURE Centre at St. Paul’s Hospital. He is a national leader in cardiovascular research and has served since 2000 as the inaugural Scientific Director of CIHR’s Institute of Circulatory and Respiratory Health. In addition to being an excellent and ...

Director, Centre for Functional and Metabolic Mapping, Western University

Pioneer in the field of functional magnetic resonance imaging (FMRI), which has become an indispensable, noninvasive tool for the study of human brain function. Early innovator in the development of technology for ultra-high field FMRI, focusing on understanding what it measures as well as the changes in anatomy and function that accompany disease and degeneration in the brain. Professor of Medical Biophysics; Director of the Centre for Functional and Metabolic Mapping at Western University; Canada Research Chair in FMRI.

Dr. Gavin Oudit has dedicated his career to the advancement of cardiovascular medicine and knowledge thereof in provincial, national and international settings through his research, education and clinical practice. He has made novel discoveries and several have translated into clinical trials including recombinant human ACE2 for lung disease and key role of ACE2 in COVID-19. He is involved with national and international societies and organizations for the promotion of cardiac research and health including in vulnerable patient groups. His leadership in enhancing translational research and ...

Professor, McGill University

Dr. Morag Park is a Professor in the Departments of Medicine, Oncology, and Biochemistry at McGill University. She is a Fellow of the Royal Society of Canada, Fellow of the Canadian Academy of Health Sciences, James McGill Professor, and holds the Diane and Sal Guerrera Chair in Cancer Genetics. Dr. Park received a B.Sc. with first class honors from the University of Glasgow, a Ph.D. in Viral carcinogenesis at the Medical Research Council Virology Institute in Scotland, and completed postdoctoral training at the National Institutes for Cancer Research in Washington DC. She was the Director of ...

Distinguished University Professor, McMaster University

Dr. Harriet MacMillan is a pediatrician, psychiatrist, and scientist whose research has transformed how family violence, including child maltreatment and intimate partner violence, is understood, responded to, and prevented. Her pioneering work has led to a better understanding of the impact of exposure to violence, and its link to mental health outcomes. She has influenced national and international guidelines and led the development and evaluation of prevention and intervention efforts. Dr. MacMillan has furthered our knowledge of the individual and societal impacts of child maltreatment ...

Dr. Mes-Masson obtained her Ph.D. from the Department of Microbiology and Immunology at McGill University in 1984 under the direction of Dr. John Hassell. From 1984-1986, she completed post-doctoral studies at the Molecular Biology Institute, University of California Los Angeles, in the laboratory of Dr. Owen Witte where she was the first to clone the full length BCR-ABL transcript implicated in Chronic Myelogenous Leukemia. After a short period as a research associate at the Biotechnology Research Institute, Dr Mes-Masson joined the Institut du cancer de Montréal and the Department of ...